# Male Infertility Linked to Higher Colorectal and Thyroid Cancer Risk
Men with infertility face elevated cancer risks beyond reproductive concerns, according to new research connecting male fertility problems to colorectal and thyroid cancers.
The study examined men diagnosed with infertility and tracked their subsequent cancer diagnoses. Researchers found that men with infertility showed higher rates of colorectal cancer and thyroid cancer compared to men without fertility problems. The connection suggests that underlying biological factors affecting sperm production or function may also influence cancer development in other body systems.
Male infertility typically stems from low sperm count, poor sperm mobility, or abnormal sperm structure. These conditions involve hormonal imbalances, genetic factors, or systemic health issues that extend beyond the reproductive system. The new findings suggest that whatever disrupts male fertility may simultaneously increase vulnerability to certain cancers.
The colorectal cancer link appears particularly notable. Colorectal cancer remains the second leading cause of cancer death in men, yet most screening recommendations focus on age rather than fertility history. Adding infertility status to cancer risk assessments could help identify men who benefit from earlier or more frequent screening.
Thyroid cancer, while less common, showed similar elevation in the infertility group. Both cancers involve cellular growth regulation, hinting at shared biological pathways affected by infertility-related health changes.
The findings carry practical implications for men seeking fertility treatment. Urologists and reproductive specialists now have stronger reason to discuss broader health monitoring with infertile patients. Men undergoing fertility evaluations should discuss cancer screening recommendations with their doctors, particularly for colorectal and thyroid cancers.
This research does not suggest infertility directly causes these cancers. Rather, shared underlying health factors may drive both conditions. Genetic predispositions, inflammatory processes, or hormonal dysregulation could simultaneously compromise